AI-powered healthtech platform DocOsage has raised pre-seed funding led by Dr Mayur Agarwal, an Angel Investor. The funds will be utilised to enhance product development, refine core-AI capabilities for health insights, and conduct early-stage testing for the telehealth and genetic studies platform, a statement from DocOsage notified today.
Varun Vashisthaa, Co-founder and CEO, DocOsage, said in the statement, “DocOsage is dedicated to transform healthcare through state-of-the-art technology. The initial funding will serve as a catalyst for launching product development, paving the way for a revolutionary health platform. DocOsage is unwavering in its commitment to shaping the future of proactive healthcare.”
Founded in October 2023 by Varun Vashisthaa, Dr Shivali Agarwal and Dr Lipi Verma, DocOsage stands as a pioneering life-long health companion app, added the statement.
Dr Lipi Verma (PT), Co-founder and Chief Medical Officer (CMO), DocOSage, also said in the statement, “We aspire to empower individuals and families through accessible and technology-driven healthcare solutions. This pre-seed round propels us towards shaping our vision by fuelling the foundational development of our innovative health platform.”
DocOsage ensures convenience with home delivery of medicines, seamless booking of investigations and diagnostics, and easy sharing of reports. Pioneering an approach to health management, use of AI for personalised health insights and future integration of telehealth and genetic testing for holistic care, DocOsage has built a community with a network of trusted doctors, allied medical experts, pharmacists and patients for support and collaboration.
Dr Mayur Agarwal, Investor and Advisor, also said, “DocOsage is not just an app, it’s a healthcare revolution. We see great potential in DocOsage’s vision and are excited to support the early stages of their healthtech solution.”
